This analysis revealed that LBX2-AS1 expression was increased in CRC tissues compared to normal tissues (Foldchange > 1.5, P < 0.05, Fig. 1A), and moreover, LBX2-AS1 exhibited gradually increasing expression from Stage I to IV CRC tissues (Fig. 1B). Here, LBX2 is linked to colorectal carcinoma.